Rapid development of vaccines and treatments for HIV and AIDS
NIAID-VRC- Rapid Manufacturing Response
['FUNDING_OTHER'] · LEIDOS BIOMEDICAL RESEARCH, INC. · NIH-10722383
This study is working on speeding up the creation of vaccines and treatments for HIV and AIDS, so that new options can be tested and made available to help people more quickly when needed.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | LEIDOS BIOMEDICAL RESEARCH, INC. (nih funded) |
| Locations | 1 site (FREDERICK, UNITED STATES) |
| Trial ID | NIH-10722383 on ClinicalTrials.gov |
What this research studies
This research focuses on accelerating the process of developing and manufacturing vaccines and treatments for HIV and AIDS. The Vaccine Research Center (VRC) is utilizing innovative technologies to shorten the timeline from initial discovery to clinical trials, ensuring that new candidates can be tested for safety and effectiveness more quickly. By streamlining the production and supply of investigational products, this initiative aims to respond effectively to public health emergencies related to HIV and AIDS.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for or living with HIV/AIDS who are interested in participating in clinical trials for new vaccines or treatments.
Not a fit: Patients who are not at risk for HIV or do not have HIV/AIDS may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster access to effective vaccines and treatments for HIV and AIDS patients.
How similar studies have performed: Other research initiatives have successfully utilized rapid development approaches for vaccine production, particularly during public health crises, indicating a promising potential for this method.
Where this research is happening
FREDERICK, UNITED STATES
- LEIDOS BIOMEDICAL RESEARCH, INC. — FREDERICK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LINDSAY, DAVID — LEIDOS BIOMEDICAL RESEARCH, INC.
- Study coordinator: LINDSAY, DAVID
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus